| Dr Valerie M Wassill, MD | |
|
333 W. Hampden Ave., Suite 600, Englewood, CO 80110-2336 | |
| (303) 761-5646 | |
| (303) 761-9280 |
| Full Name | Dr Valerie M Wassill |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Location | 333 W. Hampden Ave., Englewood, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255370847 | NPI | - | NPPES |
| 01225762 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 22576 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Valerie M Wassill, MD 333 W. Hampden Ave., Suite 600, Englewood, CO 80110-2336 Ph: (303) 761-5646 | Dr Valerie M Wassill, MD 333 W. Hampden Ave., Suite 600, Englewood, CO 80110-2336 Ph: (303) 761-5646 |
News Archive
Scientists working to develop a vaccine for the human immunodeficiency virus (HIV) report they have created the first antigen that induces protective antibodies capable of blocking infection of human cells by genetically-diverse strains of HIV. The new antigen differs from previously-tested vaccines by virtue of its chemically-activated property that enables close sharing of electrons and produces strong covalent bonding.
SciDev.Net reports on two recent studies published in the Canadian Medical Association Journal which look at how frequently health care providers and researchers in developing countries access research-based evidence.
Stem cell scientists from around the world gathered at the International Society of Stem Cell Research (ISSCR) in San Francisco to exchange information about the latest treatments with stem cells. An American company, TCA Cellular Therapy, LLC announced its FDA clinical trial results using adult stem cells in patients with history of a heart attack during open heart surgery.
TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.
› Verified 7 days ago
Dr. Wendy K Herhahn, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 333 W. Hampden Ave., Suite 600, Englewood, CO 80110 Phone: 303-761-5646 Fax: 303-761-7928 | |
Giancarlo Checa, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 10700 E Geddes Ave Ste 100, Englewood, CO 80112 Phone: 303-750-8100 | |
Alida Rae Near, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 501 E Hampden Ave, Englewood, CO 80113 Phone: 303-788-6749 | |
Dr. Bruce R. Brookens, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 333 W. Hampden Ave., Suite 600, Englewood, CO 80110 Phone: 303-761-5646 Fax: 303-761-9280 | |
Dr. Dan M Davis, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 333 W Hampden Ave, Suite 600, Englewood, CO 80110 Phone: 303-761-5646 Fax: 303-761-7989 | |
Dr. Ronald D Ellis, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 333 W Hampden Ave, Suite 600, Englewood, CO 80110 Phone: 303-761-5646 Fax: 303-761-9280 | |
Dr. Jeffrey B Dobyns, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 333 W. Hampden Ave., Suite 600, Englewood, CO 80110 Phone: 303-761-5646 Fax: 303-761-9280 |